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Abstract. The relationship between growth and cyto- 
differentiation was studied in cultured rat aortic 
smooth muscle cells (SMCs) using expression of the 
smooth muscle (SM)-specific isoactins (Vanderkerck- 
hove, J., and K. Weber,  1979, Differentiation,  14:123- 
133) as a marker for differentiation in these cells. 
Isoactin expression was evaluated by: (a) measure- 
ments of fractional isoactin content and synthesis 
([35S]methionine incorporation) by densitometric eval- 
uation of two-dimensional isoelectric focusing sodium 
dodecyl sulfate gels, and (b) immunocytological exam- 
ination using SM-specific isoactin antibodies. Results 
showed the following: (a) Loss of a-SM isoactin was 
not a prerequisite for initiation of cellular prolifera- 
tion in primary cultures of rat aortic SMCs. (b) a-SM 
isoactin synthesis and content were low in subcon- 
fluent log phase growth cells but increased nearly 
threefold in density-arrested postconfluent cells. Con- 
versely, 13-nonmuscle actin synthesis and content were 
higher in rapidly dividing subconfluent cultures than 
in quiescent postconfluent cultures. These changes 
were observed in primary and subpassaged cultures. 
(c) a-SM actin synthesis was increased by growth ar- 
rest of sparse cultures in serum-free medium (SFM; 
Libby, P., and K. V. O'Brien,  1983, J. Cell. Physiol., 
115:217-223) but reached levels equivalent to density- 
arrested cells only after extended periods in SFM (i.e., 
>5 d). (d) SFM did not further augment a-SM actin 
synthesis in postconfluent SMC cultures. (e) Serum 
stimulation of cells that had been growth-arrested in 
SFM resulted in a dramatic decrease in a-SM actin 
synthesis that preceded the onset of cellular prolifera- 
tion. These findings demonstrate that cultured vascu- 
lar SMCs undergo differential expression of isoactins 
in relation to their growth state and indicate that 
growth arrest promotes cytodifferentiation in these 
cells. 
S 
TUDIES by Chamley-Campbell et al. (2,  4) and others 
(37, 41) demonstrate that vascular smooth muscle cells 
(SMCs) ~  undergo marked changes in phenotype when 
grown in cell culture. These changes include diminished con- 
tractile filaments and contractile proteins, loss of  contractility, 
alterations in biosynthetic properties, and changes in sensitiv- 
ity to mitogens. Based on observations that most cells did not 
proliferate in cell culture until these changes occurred, Cham- 
ley-Campbell et al. (2) proposed that cells normally exist in a 
nonproliferating  contractile  state  and must modulate to a 
synthetic state before proliferating. Furthermore,  they pro- 
posed that established SMC cultures remain permanently in 
a synthetic state. However, recent studies demonstrate that 
established cultures  of SMCs continue  to  express smooth 
muscle (SM)-specific contractile proteins (10, 13, 20), retain 
high affinity receptors to various agonists (5, 18), and undergo 
a  Abbreviations  used in this paper: FCS, fetal calf serum; HBSS, Hanks' balanced 
salt  solution;  IEF,  isoelectric  focusing;  NM,  nonmuscle;  SFM,  serum-free 
medium; SM, smooth muscle; SMC, smooth muscle cell. 
agonist-induced changes in membrane conductance (5, 24). 
Whereas these studies demonstrate that cultured SMCs con- 
tinue to express a variety of  differentiated characteristics, they 
did not specifically address how growth and cytodifferentia- 
tion were related. An understanding of this relationship may 
have profound  implications  for  investigators interested  in 
studying various aspects of SMC contractile function in cul- 
tured cells, as well as in studies of growth control. It is not 
known, for example, whether present methods for inducing 
quiescence in cultured SMCs (e.g., serum-free medium [SFM, 
22], plasma-derived serum [33]) are associated with increased 
expression of cell-specific proteins indicative of entrance into 
a true Go state. 
A major limitation in previous studies ofcytodifferentialion 
in SMCs was the lack of a sensitive, easily measured, quanti- 
tative means of assessing their state of differentiation. The 
contractile proteins are logical candidates for a group of cell 
type-specific proteins whose synthesis might be coordinately 
regulated during growth and differentiation. This is true in 
skeletal muscle, where cessation of  myoblast proliferation and 
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in myosin synthesis, and a switch in actin synthesis from the 
nonmuscle isoactins (i.e., ~- and 3,-nonmuscle [NM]), to the 
skeletal a-isoactin form that makes up nearly all of the actin 
in fully differentiated skeletal muscle cells (6). Similar altera- 
tions in expression of muscle and nonmuscle actins appear to 
occur during differentiation of smooth muscle (12,  29,  34). 
Based on amino acid sequence analysis, Vandekerckhove and 
Weber (38)  demonstrated that SMCs express  four different 
actin polypeptides or isoactins, each representing a different 
gene product. These include two SM- specific isoactins (a-SM 
and  3'-SM;  note that  a-SM  is  distinct  from the  a-isoactin 
found in skeletal and cardiac muscle) and two isoactins ex- 
pressed in nonmuscle cells (~3-NM and 3,-NM), where the a-, 
/~-, and 3'- designate variants distinguishable on the basis of 
their isoelectric points. In developing smooth muscle tissues 
nonmuscle actins predominate, whereas more than 70%  of 
the actin in differentiated smooth muscle is of the a-SM and 
3"-SM types (39). The ratio of a-SM to 3"-SM varies between 
different  smooth  muscle  tissues  (9).  In  rat  aortic  smooth 
muscle -94%  of the smooth muscle-specific actin is of the 
a-SM type (39). 
In the present investigation, we explored the interrelation- 
ship between cytodifferentiation and growth in cultured rat 
aortic SMCs by using expression of a-SM actin as a marker 
for differentiation in these cells. Our specific objectives were: 
(a) to determine whether loss of a-SM actin was a prerequisite 
for initiation of proliferation in primary vascular SMC cul- 
tures, (b) to determine the time-course of changes in isoactin 
expression in relation to growth state in both primary and 
subpassaged SMC cultures, and (c) to explore whether growth 
arrest of cells in a defined serum-free medium (22) is associ- 
ated with increased expression of a-SM isoactin. 
Materials and Methods 
Cell Culture 
Rat thoracic aortic SMCs were isolated and cultured by a modification of the 
procedures described  by Chamley-Campbell et al. (2).  Male Sprague-Dawley 
rats (Hilltop Lab Animals, Inc.,  Scondale, PA) weighing ~200-225  g  were 
killed by CO2 asphyxia,  and the thoracic aorta from the descending  thoracic 
aorta to the diaphragm aseptically excised and placed in Hanks' balanced salt 
solution (HBSS, Gibco, Grand Island, NY). Adhering fat and connective tissue 
were removed by blunt dissection.  Vessels were then opened longitudinally  and 
preincubated  in HBSS containing 1 mg/ml collagenase  (type CLS II,  146 U/ 
mg, Worthington Biochemical Corp., Freehold,  NJ), 0.5  mg/ml elastase (type 
I, 32 U/mg, Sigma Chemical Co., St. Louis, MO), penicillin (100 U/ml), and 
streptomycin (100 ~g/ml) for 15-20 min at 37"C, in 95%  air/5%  CO2. The 
adventitia  was carefully removed under a dissecting microscope and the luminal 
surface scraped with forceps to remove endothelial cells. After dissection, aortas 
were placed in fresh enzyme solution, minced into l-mm pieces, and incubated 
(37°C, 95% O2, 5% CO2) for an additional 1.5-2,0 h with tituration at 30-min 
intervals.  The resulting  cell-tissue suspension was filtered through a  85-/~m 
stainless steel mesh. The filtrate was collected  and 20%  fetal calf serum (FCS, 
Gibco) added to inactivate enzymes. Cells were centrifuged ( 113 g, 8 rain) and 
the cell pellet resuspended  in medium-199 (Gibeo) containing 10% FCS plus 
the above antibiotics.  Cells were counted in triplicate in a hemocytometer,  and 
cell  viability  assessed  by trypan blue exclusion. Cells were then seeded  at a 
density of 1.0 x  104 viable cells cm  -2 in plastic culture dishes (Coming Glass 
Works, Coming, NY). 
Cells were harvested for passaging at 2-wk intervals with a trypsin (0.01%, 
VMF, Worthington Biochemical Corp.), EDTA (0.02%, Sigma Chemical Co.) 
solution and  plated  at  104  cells cm  -2.  Passaged  cells were  grown in  either 
medium-199 containing 10%  FCS  plus antibiotics or in SFM  (22) with or 
without 10%  FCS supplementation depending on the experiment. SFM con- 
tained equal parts of Dulbecco's modified Eagle's medium (Gibco) and Ham's 
F-12 (Gibeo) supplemented with insulin (10  -~ M, Sigma Chemical Co.), trans- 
ferrin (5 vg/ml, Sigma Chemical  Co.), ascorbate (0.2 raM,  Sigma Chemical 
Co.),  and  antibiotics.  This  SFM  has been  shown to  maintain  SMCs  in  a 
quiescent, noncatabolic, viable state for extended time periods (22). Cell cultures 
were incubated  at 37"C in a humidified atmosphere  of 5% CO2/95% air with 
media changes three times weekly. 
Growth Curves 
Cultures were washed, trypsinized, and monodispersions counted  in a hemo- 
cytometer with four counts for each dish and triplicate dishes for each sample 
point. 
~ H]Thymidine A utoradiography 
Cells were pulse labeled for  1 h with [~H]thymidine ( 1 uCi/ml, 6.7 Ci/mmol, 
New England Nuclear, Boston, MA) in regular culture medium. Cultures were 
then washed twice with HBSS, fixed in 2% paraformaldehyde  in HBSS for 5 
min, dehydrated, coated with Kodak NTB2 emulsion (diluted 1  : 1 with distilled 
water), and exposed for 7 d at 4"C. Dishes were developed in D-19 (Eastman 
Kodak Co., Rochester, NY), fixed with Rapid-Fix (Eastman Kodak Co.), and 
stained with hematoxylin. The percentage of labeled nuclei was determined  by 
counting  a random sample  of at least 2,000 cells from each dish. Duplicate 
dishes were analyzed for each sample point. 
For continuous labeling experiments, cells were pulsed at 24-h interva!s with 
0.01 ~Ci/ml  [3H]thymidine. To ensure  that the labeled thymidine  was not 
degraded and could label cells over the entire 24-h pulse period, [3H]thymidine- 
containing medium was removed from cells at the end of  a 24-h labeling period 
and placed on fresh cells for 1 h. Labeled cells were observed, indicating that 
labeled thymidine was biologically active. Growth curves of SMCs grown with 
and without 0.01 uCi/ml [3H]thymidine were not different, indicating that this 
dose of [3H]thymidine did not itself influence cell growth. 
Antibody Staining 
The specificity of the  SM isoactin  monoclonal  antibody  (designated CGA7) 
used in these studies has been reported previously (16). This CGA7 antibody is 
specific for the a-SM and -/-SM isoactins, but does not react with either cardiac 
or skeletal muscle c~-isoactins or with ~3- and 3,-NM isoactins. 
Cells for combined  immunocytological  staining and autoradiography  were 
grown in Bellco microslide culture chambers (Bellco Glass, Inc., Vineland, N  J) 
containing  plastic  slides  cut  from  our  regular  culture  dishes  as  a  growth 
substrate. This facilitated immunocytologlcal staining without altering cellular 
growth properties. At designated times cells were rinsed briefly with HBSS and 
fixed in methanol  (4"C, three changes over 5 min). Slides were air-dried and 
stored desiccated at 4"C until used. 
Antibody staining was done using an avidin-biotin-peroxidase  procedure 
(Vectastain, Vector Laboratories, Burlingame, CA). Stained cells were examined 
by  light  microscopy  and  then  processed  for autoradiography  as  described 
elsewhere. 
The following controls for specificity of staining were done: (a) substitution 
of the primary antibody  with nonimmune mouse serum or with an antineu- 
rofilament monoclonal antibody; (b) exclusion of both antibodies; or (c) exclu- 
sion of the primary antibody alone. 
Measurements of Contractile Proteins 
Sample Preparation. Cells were removed from culture dishes by trypsinization, 
centrifuged (120 g,  10  min),  washed with  phosphate-buffered  saline (PBS), 
recentrifuged, and cell pellets frozen immediately in a dry ice-acetone slush and 
stored at -80"C until assayed. The samples were then thawed and solubilized 
at 103-104 cells/ul in isoelectric focusing (IEF) medium as described by Driska 
et at. (7). 
lsoactin  Determinations:  Two-dimensional  Gel Electrophoresis. A modifi- 
cation of O'Farrell's  (27) two-dimensional IEF/SDS electrophoretic technique 
described by Fatigati and  Murphy (9) was used for resolving isoactins. This 
method uses a pH gradient of  4.0-6.5 (Pharmalyte, Pharmacia Fine Chemicals, 
Piscataway, N  J). Samples contained  3-20 t~g of protein (23). After completion 
of electrophoresis in the second dimension, gels were either silver stained (26) 
and dried between two sheets of  cellophane (40) for autoradiography, or stained 
with Coomassie Blue (8) for densitometric  protein determinations.  Identifica- 
tion of actins was done by: (a) co-electrophoresing our samples with purified 
skeletal muscle actin or endothelial cell lysates; (b) immunoblotting with actin 
antibodies; and (c) comparison to published results of others (9, 38). 
Coomassie Blue-stained  gels were scanned with a pinpoint light source at a 
wavelength of 525 nm as described by Fatigati and Murphy (9) for determina- 
tions of fractional isoactin contents.  A Quick  Scan Jr. densitometer,  custom 
modified  with high resolution  optics (Helena  Laboratories,  Beaumont,  TX), 
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determine  maximal  optical  densities. The method was reproducible  with re- 
peated  measurements  on  the  same  sample  (i.e., the  ratio  of the  standard 
deviation  to the mean was 8.4%) and was linear  over the  range of protein 
loadings used. 
Fractional Incorporation  oft s  S]Methionine into lsoactins. Cells were pulsed 
with [3SS]methionine  (986-1,103  Ci/mmol, New England Nuclear) for either 4 
h (80 ~Ci/ml) or for 12 h (40 ~Ci/ml) depending on the experiment. Samples 
containing  10,000-60,000  trichloroacetic  acid-precipitable  cpm were applied 
per IEF gel and the isoactins resolved as described above.  Kodak  X-OMAT 
AR or K film, with exposure times of 24 h or 1-2 wk, respectively, was used 
and the autoradiographs  scanned with an Optronics P-1000 densitometer. The 
fractional  [~SS]methionine incorporation  into each  isoactin  was quantitated 
using a nonlinear least squares Gaussian  curve fitting algorithm described by 
Garrison and Johnson  (14). Repeated evaluations of  the same sample (including 
the use of both types of film) showed a standard  deviation that was less than 
5% of the mean. 
lmmunoblot Analyses oflsoactins, lsoactins were resolved by IEF/SDS gel 
electrophoresis  as described  above,  transferred  to  nitrocellulose  paper,  and 
immunoblot analyses done as described by Gown et at. (16). Primary antibody 
titers  used  were  between  2.5  and  20.0  ~g protein  ml  -~.  Controls  included 
exclusion of primary  antibodies  or substitution  of primary  antibody  with an 
antineurofilament  monoclonal  antibody.  The following actin antibodies were 
used: (a) CGA7, an SM-specific isoactin monoclonal  antibody (16) (a gift from 
A. Gown, University of  Washington); (b) B4, an SM-specific isoaetin monoclo- 
nal antibody (21) (a gift from J. Lessard, University of Cincinnati); and (c) C4, 
a monoclonal that reacts with all isoactins (21) (also from J. Lessard). 
Results 
Cell Growth in Primary Vascular Smooth 
Muscle Cultures 
A representative growth curve of rat aortic SMCs in primary 
culture  is presented  in Fig.  1.  Cell  viability,  determined  by 
trypan blue exclusion,  was >95%  in  freshly dispersed  cells. 
Plating efficiencies were between 40 and 60%. After plating, 
attached cells began to spread within  24-36 h  and initiated 
DNA synthesis within  24 and 48  h  after plating.  (Fig.  3 a). 
Cells grew logarithmically for a period of 6-7 d during which 
the doubling time  was ~ 1.8  d.  Cells typically became con- 
fluent by 6-7 d  and reached saturation density (1.25  ×  105 
cells cm  -2) by 9-11 d. The time to onset of growth, doubling 
times,  and  saturation  densities  were  very  similar  between 
different primary culture preparations. Cells grew in the typ- 
ical hill and valley pattern characteristic of SMCs and formed 
multiple  cell layers based on both light and electron micro- 
scopic examination. 
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Figure 1. Growth curve of rat aortic SMCs in primary culture. Cells 
were grown in medium  199  +  10%  FCS.  Initial plating density was 
104 cells cm  -2.  Cells were harvested using a  trypsin-EDTA,solution 
and counted in a hemocytometer.  Each point represents the mean + 
SEM from at least three dishes. At several points the SEM is less than 
the radius of the point and is not visible. 
Figure 2. Two-dimensional gels showing the fractional content (Coo- 
massie Blue-stained  gel) and synthesis (autoradiographs) of isoactins 
in rat aortic SMCs at 2.5 d, 5.5 d, and  10 d in primary cell culture. 
Duplicate  culture dishes were pulsed with  [35S]methionine (4 h, 80 
#Ci/ml).  Samples were harvested, pooled, and isoactins resolved by 
two-dimensional  IEF/SDS gel electrophoresis.  Pooling  of samples 
from  replicate  dishes was  necessary to have  sufficient  sample  for 
analysis. The total radioactivity loaded on each gel was approximately 
the same.  Note that relative  a-SM  actin  content was high  but its 
synthesis extremely low in cells at 2.5 d. At 5.5 d, a-SM actin synthesis 
and content were low. At I0 d, cells were postconfluent and both a- 
SM actin content and synthesis were increased compared with earlier 
times in culture.  Results of densitometric  evaluations  are shown in 
Fig. 3. 
Changes in Isoactin Content and Synthesis in 
Relation to Cellular Growth in Primary Culture 
Three isoelectric variants of actin were identified in cells by 
two-dimensional IEF/SDS gel electrophoresis (Fig. 2). Amino 
acid sequence analysis by others (38) has demonstrated that 
the a-isoelectric variant consists only of the a-SM type, that 
the #-NM actin is identical to that found in other nonmuscle 
cells,  while the ~-isoelectric variant includes both the 3,-SM 
and  q,-NM  actins.  Thus,  all  references  to  -y-actin  in  this 
manuscript  reflect both the  muscle and  nonmuscle compo- 
nents. 
Major changes in fractional isoactin content and synthesis 
occurred when  SMCs were grown in  culture.  Figs.  2  and  3 
show results of a  representative experiment, whereas Table I 
summarizes data from several different replicate experiments. 
SMCs in freshly isolated intact vessels contained ~70% a-SM 
actin  with  relatively  small  amounts  of #-NM  and  ~-actin. 
Likewise, the major actin synthesized in intact vessels was a- 
SM.  No detectable  changes in  actin  content were  observed 
within 36-48 h of plating (Fig. 3 c, and Table I, B). However, 
a  dramatic decrease in the fractional synthesis of a-SM actin 
and an increase in #-NM and ~-actin synthesis (P <  0.001, 
analysis of variance) occurred within 36 h of plating (Fig. 3 b, 
Table I, B). Significantly, these changes preceded the onset of 
DNA synthesis as determined by [3H]thymidine autoradiog- 
raphy  (Fig.  3a).  Thus,  whereas  cells  at  early  time  points 
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Figure 3. Changes in isoactin expression (Fig. 3,  b and c) in relation 
to cellular growth rates (a) in primary rat aortic SMC cultures. Cells 
were plated at  1.0 x  104 cells cm  -2 in medium  199  +  10%  FCS. At 
various  times,  dishes  were  selected for determination  of cellular 
growth rates (frequency of [3H]thymidine-labeled cells) or fractional 
isoactin content and synthesis as described in Materials and Methods. 
Replicate dishes were pooled  for gel electrophoretic  analyses. The 
labeling index was determined  on at least two dishes at each time 
point.  The initial  time point (i.e., 0 d) reflects values obtained  in 
intact vessels. In this case, thymidine labeling indices were determined 
by injecting rats with 50 •Ci/100  g [3H]thymidine  1 h before they 
were killed and measuring the frequency of labeled SMCs in tissue 
sections by autoradiography.  Relative isoactin content and synthesis 
was determined  by incubating  freshly obtained  thoracic  aortas  in 
medium-199 containing  80 uCi/ml [35S]methionine (3 h, 37"C, 95% 
air,  5%  CO2). Medial  preparations  of thoracic  aortas  were  then 
prepared,  homogenized, and gels run as described in Materials and 
Methods. Results from several replicate experiments are summarized 
in Table I. 
contained significant a-SM actin, the fractional synthesis of 
this actin was extremely low. These early changes in fractional 
isoactin synthesis were followed by a corresponding drop in 
a-SM  actin  content  and  an  increase  in  3-NM  and  3,-actin 
content,  a-SM  actin synthesis and content (Figs. 2 b and  3, 
and Table I, C) was low but not absent in subconfluent cells 
during exponential growth, a-SM actin synthesis increased in 
conjunction with a decrease in growth rate between day 5.5 
and day 10 after plating as cells reached confluence (Figs.  2c 
and  3 b) and was followed by a  nearly threefold increase in 
the fractional content of a-SM actin between 7.5 and  13.5 d 
(Fig. 3 c, and Table I, D). The increase in a-SM actin content 
and synthesis in postconfluent cells as compared with subcon- 
fluent cells was significant at the P <  0.001  level (Table I, C 
vs D).  Density  arrest  of growth  is  thus  associated  with  in- 
creased expression of a-SM actin and decreased expression of 
3-NM actin, while expression of 3,-actin (i.e.,  "r-SM +  3,-NM) 
was  relatively  unchanged.  Significantly,  these  changes  oc- 
curred in the presence of 10% FCS. 
Simultaneous Evaluation of  Actin Expression and 
DNA Synthesis in Individual SMCs: Combined 
Immunocytochemical and Autoradiographic Studies 
To directly explore the interrelationship between growth state 
and actin expression on an individual cell basis the following 
experiment  was done.  Primary cultures were  prepared  and 
grown in the continuous presence of low levels of [3H]thy- 
midine (0.01 #Ci/ml). Cells were harvested at 24 h, and then 
at 48-h intervals between 1 and 11 d. Cells were fixed, stained 
with the SM-specific isoactin antibody CGA7, processed for 
autoradiography, and observed by light microscopy. 
At the 24-h time point, all cells appeared to stain positively 
with  the CGA7  isoactin antibody.  This indicates  that  non- 
SMC contaminants were rare and that there was not a  sub- 
population of SMCs deficient in SM isoactins. In addition, as 
illustrated in Fig. 4 a, there were clearly cells present at early 
time  points  that  had  initiated  DNA synthesis and  were  si- 
multaneously stained with the CGA7 antibody. This and our 
gel electrophoretic analyses presented earlier (Figs. 2 and  3) 
demonstrate that total loss of SM isoactins was not a prereq- 
uisite for initiation of DNA synthesis. 
The staining intensity with the CGA7 antibody appeared 
to be uniformly decreased in exponentially growing cells (days 
5  and  7),  suggesting  that  the  SM  actin  present  in  rapidly 
growing cultures did  not reside  in a  subpopulation  of cells 
with a high SM actin content. Significantly, these observations 
also suggest that the major portion of the 3,-actin present in 
subconfluent cultures is of the 3,-NM type since the CGA7 
antibody used  recognizes only a-SM and  7-SM actin.  This 
conclusion was supported by results of immunoblot analyses 
discussed  below.  A  moderate  increase  in  staining  intensity 
with the CGA7 antibody occurred in postconfluent cells that 
likewise appeared to be uniform among cells. 
Immunoblot Analysis of SM Isoactins in 
Primary Cultures 
As  noted  previously,  IEF/SDS  gel  electrophoretic  analysis 
does  not  distinguish  between  the  ~,-SM  and  7-NM  actin 
forms. To determine whether the -y-SM actin is also expressed 
in cultured SMCs, Western blot analyses were performed on 
isoactins derived  from subconfluent  and  postconfluent pri- 
mary cultures, using several isoactin monoclonal antibodies 
(data not shown). While the CGA7 antibody (16) showed a 
high degree of cell specificity when staining whole cells,  this 
antibody showed low reactivity in immunoblot analyses, sug- 
gesting that  the  antigenic  determinant  for this  antibody  is 
altered during electrophoretic and transfer processes. The C4 
antibody  (21),  used  as  a  positive  control,  reacted  with  all 
isoactins from both subconfluent and postconfluent cells. The 
B4 antibody (21 ) showed specific staining of a-SM and 3,-SM 
actins from fresh homogenates of rat aortic smooth muscle, 
but did not react with 3-NM or with 3,-NM actin from several 
sources. As reported previously (21), B4 appeared to be selec- 
tive for the 3,-SM  as compared with a-SM  (21).  There also 
appeared to be some loss of antigenicity with  B4 in immu- 
noblots since high antibody titers and protein loadings were 
necessary  in  our  studies.  Significantly,  the  B4  antibody 
showed little or no reactivity with ~,-actin  from subconfluent 
SMCs but showed reactivity with 3,-actin from postconfluent 
SMCs. Thus, a portion of the 7-actin in these cells is of the 
SM  type.  However,  due  to  the  limited  sensitivity  and  the 
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Culture 
a-SM  B-NM  7-SM + 3'-NM 
Group  Content  Synthesis  Content  Synthesis  Content  Synthesis 
A  Intact aortas 
B  Pre-growth cultures ( 1 d) 
C  Subconfluent cultures (3-6 d) 
D  Postconfluent cultures (10-14 d) 
70.1  4- 2.1  66.7 4-  1.6  19.3 4-  1.1  24.6 4-  1.7  10.5 4-  1.1  8.7 4-  1.9 
n=5  n=5  n=5  n=5  n=5  n=5 
70.0 4- 0.2  2.0 4- 2.0  *~  20.2 4- 3.9  68.8 4-  1.3 *~  9.7 4- 0.2  29.3 4- 0.8  *~ 
n=4  n=2  n=4  n=2  n=4  n=2 
(3)  (2)  (3)  (2)  (3)  (2) 
17.1  4- 2.8  *u~  13.3 4- 2.0  *l~  58.3 4- 2.1 *u~  54.9 4-  1.6  *11'  24.4 4-  1.6  *~  31.8 4-  1.2  *~m 
n=4  n=6  n=4  n=6  n=4  n=6 
(2)  (2)  (2)  (2)  (2)  (2) 
34.9 4- 4.0  ~  35.8 4- 4.5  ~  47.6 4- 2.5  ~  44.3 4- 2.1 ~  17.6 4-  1.7  ~  17.9 4- 2.3  ~ 
n=5  n=5  n=5  n=5  n=5  n=5 
(3)  (3)  (3)  (3)  (3)  (3) 
All values represent mean _+ SEM. n, number of individual samples. Data from several independent replicate experiments are combined in this table. The number 
of separate experiments from which samples were derived is indicated in parentheses. A, Freshly obtained thoracic aortas were incubated in medium-199 containing 
80 uCi/ml [~SS]methionine (3 h, 37"C, 95% air, 5% CO2). Medial preparations of thoracic aortas were prepared homogenized, and gels run as described in Materials 
and Methods. n, number of animals. B. Primary cultures harvested at  1-2 d after plating and before  initiation of DNA synthesis (see Fig. 3a). C, Subconfluent 
cultures harvested while growing exponentially. D, Cultures were 3-5 d postconfluent. Growth rates were extremely low and cells were at saturation density. 
* Expressed as a percentage of total actin synthesis  or content (see Material and Methods). 
Values are significantly different from that of intact vessels (P <  0.001, analysis of variance). 
! Fractional isoactin synthesis  and content are significantly different (P <  0.025,  analysis of variance). 
i C is significantly different from D (P <  0.05, analysis of variance). 
i Significantly  different from B (P <  0.05, analysis of variance). 
qualitative nature of these analyses, we are reluctant to make 
any definitive statements regarding the relative abundance  of 
7-SM actin in subconfluent versus postconfluent cells. 
Figure 4.  Simultaneous evaluation of [3H]thymidine incorporation 
and isoactin expression in rat aortic SMCs after 3 d in primary culture 
using the CGA7  monoclonal antibody for SM  isoactins (i.e.,  a-SM 
and 7-SM). Cells were isolated as described in Materials and Methods 
and grown in the continuous presence of [aH]thymidine (0.01  uCi/ 
ml) in  medium-199 +  10%  FCS. Cells were stained with either the 
CGA7  isoactin  antibody  (a)  or  control  nonimmune  antibody  (b) 
using an avidin-biotin-peroxidase procedure.  Cells were then  fixed 
in 2% glutaraldehyde and processed for autoradiography.  Note that 
several cells that stained with the CGA7 SM isoactin antibody (a), as 
well  as control  cells (b),  have incorporated  [3H]thymidine.  Bar,  25 
gm. 
Expression of lsoactins in Subpassaged SMCs 
To  determine  whether  the  observed  changes  in  isoactin 
expression were unique adaptations of primary cultures, pri- 
mary cells at saturation density were harvested, plated at  1.0 
×  104 cells cm  -2 in SFM +  10% FCS,  and fractional isoactin 
synthesis and content determined in subconfluent cells during 
exponential  growth  as  well  as  in  postconfluent  density-ar- 
rested  cells  (Table  II,  A  and  B).  As  observed  in  primary 
cultures, the fractional synthesis and content of a-SM actin 
were  significantly  increased  while  fl-NM  and  3,-actin  were 
decreased in postconfluent versus subconfluent ceils.  In fact, 
the fractional levels of c~-SM actin synthesis and content in 
subpassaged postconfiuent cultures (Table II) were not signif- 
icantly different from those of primary cultures (P >  0.05, 
analysis of variance). 
The time-course of changes in  fractional a-SM actin syn- 
thesis,  relative  to  changes  in  cell  number  and  replicative 
frequency, is illustrated in Fig. 5 (i.e., see the 10% FCS group). 
As in primary cultures, the increase in a-SM actin synthesis 
coincided with density-induced decreases in cellular growth 
rates that occurred as cells reached confluency (Fig. 6 c). 
Effects of Growth Stimulation and Growth Arrest on 
Actin Expression in Subpassaged SMCs 
The preceding experiments have demonstrated that density- 
arrest  of growth  is  associated  with  increased  a-SM  actin 
expression and that this occurs even in the presence of 10% 
FCS.  The following series of experiments were designed to 
determine (a) whether growth arrest of subconfluent cells in 
SFM could evoke similar increases in a-SM actin expression, 
and (b) to explore whether subsequent growth stimulation of 
SFM-arrested cells with FCS was associated with decreased a- 
347  Owens et al. lsoactin Expression in Cultured Smooth Muscle Cells Table H. Fractional Isoactin Synthesis and Content* in Passaged Rat Aortic Smooth Muscle Cells." Effects of Growth State 
a-SM  /3-NM  y-SM +  y-NM 
Group  Content  Synthesis  Content  Synthesis  Content  Synthesis 
A  Subconfluent cultures in 10% FCS 
B  Postconfluent cultures in 10% FCS 
C  Subconfluent cultures plated and grown  in SFM 
for 2.5 d 
D  Cultures from C 12 h after stimulation with 10% 
FCS 
E  Subconfluent cultures plated and grown  in SFM 
for 5-7 d 
F  Subconfluent cultures grown in 10% FCS for 2.5 
d and then switched to SFM for 5 d 
12.4 ___  1.2  14.4 ___  1.3  60.5 ----- 1.2  59.2 ----_ 1.6  27.1  +_ 0.8  26.3 ----- 1.4 
n=6  n=5  n=6  n=5  n=6  n=5 
(3)  (2)  (3)  (2)  (3)  (2) 
28.3 _+  1.4'  33.8 +  1.5'  55.5 _  1.5'  50.5 +  1.3*  16.2 _+ 0.3*  15.0 +  0.8* 
n=7  n=7  n=7  n=7  n=7  n=7 
(3)  (3)  (3)  (3)  (3)  (3) 
--  27.2 + 2.0'~  --  55.0 _+ 0.4*§  --  17.8 _+ 0.6* 
n=4  n=4  n=4 
(2)  (2)  (2) 
--  7.8 _+ 2.0 N  --  64.7 _+ 9.4  --  27.6 +_ 7.3 
n=2  n=2  n=2 
(2)  (2)  (2) 
--  32.6 _+ 3.0*  --  49.8 _+ 2.1'  --  17.6 + 0.9* 
n=2  n=2  n=2 
(2)  (2)  (2) 
--  33.3 + 0.9*  --  50.3 + 2.2*  --  16.6 _+ 1.3' 
n=2  n=2  n=2 
(2)  (2)  (2) 
All values represent mean -+ SEM. n, number of individual samples. Data from several independent replicate experiments are combined in this table. The number 
of separate experiments which samples were derived is indicated in parentheses. In addition, as noted in Materials and Methods, it was necessary to pool replicate 
culture dishes for each sample point within a given experiment in order to have sufficient sample for analysis. A, Cultures were plated at 104 cells cm  -2 and grown 
in SFM  +  10%  FCS. Cells were harvested when subconfluent while growing exponentially (2-4 d  postplating). [~H]Thymidine labeling indices (l-h pulse) were 
>30%. B, Cultures were plated and grown as in A. Cells were harvested between 4 and 6 d after reaching confluence or ~ 10-14 d  after plating. At this time cells 
had reached saturation density and [3H]thymidine labeling indices were (l-h pulse) <  2%. C, Cells were plated (I.0 x  104 em  -2) and grown in SFM alone for 2.5 d. 
Cell number was unchanged over this time interval and the [3Hlthymidine labeling index was <5%. D, Cells were growth-arrested in SFM for 2.5 d (C) and then 
growth-stimulated by addition of 10% FCS. Cells were harvested 12 h after addition of FCS. E, Same as C but harvested 5-7 d after plating. F, Cells were plated 
(104 cells cm  -a) in SFM and 10% FCS for 2.5 d and then growth-arrested in SFM alone for 5 d. Thymidine labeling indices were <2%. 
* Expressed as a percentage of total actin synthesis or content (see Materials and Methods). 
* Significantly different from A (P <  0.001 for a- and 3,-; P <  0.05 for/3-, analysis of variance). 
0 Significantly different from B, E, or F (P <  0.05, analysis of variance). 
i Significantly less than A, B, (7, E, or F (P <  0.05, analysis of variance). 
SM actin expression. In these experiments, cells were plated 
(1.0  X  10  4 cells cm  -2) and grown in either SFM or SFM + 
10%  FCS. At 2-3 d, some dishes were harvested from each 
group while others were switched to either SFM or SFM + 
10%  FCS and sampled at various times for determination of 
fractional isoactin synthesis, the frequency of [3H]thymidine- 
labeled cells, and cell number. Results from a  representative 
experiment are presented in Fig. 5, while results from several 
separate experiments are summarized in Table II. The relative 
cell densities present at various times are illustrated in Fig. 6. 
Cells plated and maintained in SFM for 2.5 d had a fivefold 
lower labeling index (Fig. 5 b) and a twofold lower cell number 
(Fig. 5 c) than cells grown in SFM +  10%  FCS. Significantly, 
fractional a-SM actin synthesis (Fig. 5 a and Table II, C) was 
increased twofold (P <  0.001) in these growth-arrested cells, 
while the  synthesis of/3-NM  (P <  0.05)  and  3,-actin (P < 
0.001)  was  decreased,  a-SM  actin  synthesis increased with 
time in cells maintained in SFM (Fig. 5 a) and by 5-7 d was 
not significantly different from that of postconfluent ceils in 
10%  FCS (Table II, B  vs E). These results demonstrate that 
fractional synthesis of a-SM actin can be promoted in sub- 
confluent SMCs by maintenance in SFM but the effect ap- 
pears to require an extended period of growth arrest. 
When cells plated in SFM +  FCS were switched to SFM 
alone, fractional a-SM actin synthesis was initially  moderately 
increased compared with cells that remained in FCS (Fig. 5 a), 
but by 96 h  a-SM actin synthesis was greater in cells in FCS 
than  in  cells switched to  SFM  (note  that  cell density was 
increased in the FCS group at this time). However, as observed 
in cells plated directly in SFM, a-SM actin synthesis increased 
with time in SFM (Fig. 5 a) and by 5-7 d  after switching to 
SFM,  a-SM  actin  synthesis  was  not  significantly different 
from postconfluent cultures in  10% FCS (Table II, B vs F). 
In contrast to the effects of  growth arrest, serum stimulation 
of SFM-arrested cells induced  a  dramatic  decrease  in  the 
fractional synthesis of a-SM actin within  12 h of stimulation 
(Fig.  5a,  and  Table  II, D).  Conversely, B-NM  and  y-actin 
synthesis appeared to  be  increased  although  these  changes 
were not statistically significant. It is important to note that 
the decreases in a-SM actin synthesis preceded a large increase 
in thymidine labeling index (i.e., from  3.4-28.2%)  that oc- 
curred between  12  and  24  h  after growth stimulation (Fig. 
5b). 
To  determine  whether  withdrawal  of FCS  from  cells at 
saturation  density  could  further  enhance  fractional  a-SM 
actin synthesis, cells were grown to saturation density in SFM 
+  FCS and then switched to SFM alone (Fig. 7). No increases 
in fractional a-SM actin synthesis or content (data not shown) 
were observed in two separate experiments. Cell number was 
not different between the FCS and SFM groups in this exper- 
iment, and although the thymidine labeling index decreased 
in the SFM group, it was < 1% for all groups. 
Discussion 
Chamley-Campbell et al. (2, 4) and others (37) have presented 
evidence  suggesting  that  SMCs  do  not  proliferate  in  cell 
culture until they have lost much of  their contractile apparatus 
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Figure 5.  Representative experiment showing the effects of growth 
stimulation (i.e.,  SFM  +  10%  FCS)  and growth arrest (i.e.,  SFM 
alone) on the fractional synthesis of a-SM actin (a) in cultured rat 
aortic SMCs. Fractional isoactin synthesis was measured as described 
in Materials and Methods. Cells were plated at 1.0 x  10  ~ cells cm  -2 
in either SFM or SFM +  10% FCS and some dishes harvested at 2.5 
d after plating. At 2.5 d some dishes from each group were switched 
to either SFM or SFM  +  10%  FCS and the fractional synthesis of 
isoactins determined at the times indicated. Replicate dishes (two per 
time point) were analyzed for cell number (c) and the frequency of 
cells undergoing DNA  synthesis (b). Portions of this and replicate 
experiments are summarized in Table II. 
as  visualized  by transmission  electron  microscopy and  by 
immunocytochemical staining with an SMC-specific myosin 
antibody. These investigators have suggested that SMCs nor- 
mally exist in  a  nonproliferating contractile state and that 
cells must phenotypically modulate as a prerequisite for cell 
proliferation. However, results of the present study demon- 
strate that in  primary cultures, cells that  had  incorporated 
[3H]thymidine simultaneously stained with a monoclonal an- 
tibody to the SM-specific isoactins. Furthermore, gel electro- 
phoretic analysis showed that significant a-SM isoactin was 
present in cells at the time of onset of cell replication. Larsen 
et  al.  (20)  demonstrated  continued  myosin  expression  in 
primary and established cultures of  rat mesenteric SMCs using 
antimyosin antibodies and gel electrophoretic measurements. 
Thus, loss of cell-specific contractile proteins is not a prereq- 
uisite for initiation of DNA synthesis in primary cultures of 
rat vascular SMCs. However, our studies do show that SMCs 
in both primary and subpassage undergo differential expres- 
sion of SM- and NM-isoactins in relation to growth. Frac- 
tional synthesis and content of a-SM actin was low and NM 
actins  high  in  sparse  cultures  during  rapid  growth,  while 
density arrest of growth was associated with increased a-SM 
actin and decreased #-NM synthesis and content. Our results 
are  similar to  those  of Strauch  and  Rubenstein  (36)  who 
observed that BC3H~ cells, a SM-like cell line derived from a 
mouse brain tumor, increase their synthesis of SM isoactins 
when serum-deprived. These results should be interpreted as 
evidence that  expression  of cell-specific characteristics and 
cellular  growth  are  coupled  rather  than  as  evidence  that 
phenotypic modulation is a  prerequisite for SMC prolifera- 
tion.  Furthermore, these  observations and  those  by others 
demonstrating that subpassaged cells continue to express a 
variety of characteristics of contractile responsiveness (5,  10, 
13,  18, 24, 35) clearly demonstrate that the concept of con- 
tractile state and synthetic state is somewhat misleading and 
overly simplistic in describing the differentiated state of  SMCs 
in culture. 
Density arrest of growth in both primary and subpassaged 
SMCs in the present study was associated with an increase in 
the fractional synthesis and content of a-SM actin that oc- 
curred  before attainment  of saturation  density  and  in  the 
presence of serum. While results of Strauch and Rubenstein 
(36)  are qualitatively very similar to  ours,  density-induced 
increases in a-SM actin in the presence of serum appeared to 
be attenuated in their BC3H,  cells. This may reflect, in part, 
a decreased sensitivity of BC3H] cells to density-induced de- 
creases in cellular growth and subsequent induction of a-SM 
actin expression. Strauch and Rubenstein (36)  found that a- 
SM actin synthesis could be induced much sooner in BC3H, 
cells  by growth  arresting  confluent  cells  by withdrawal  of 
serum, but no changes in a-SM actin synthesis were observed 
if cells were serum-deprived when subconfluent,  suggesting 
that cell confluence was a prerequisite for a-SM actin induc- 
tion. In contrast to their findings, the following observations 
in our studies demonstrate that a-SM actin expression can be 
promoted by growth arrest of subconfluent rat aortic SMCs. 
(a) Plating and maintenance of cells in SFM increased ~-SM 
actin  synthesis  compared with  cells  in  SFM  +  FCS  even 
though cell densities were very low. (b) Extended growth arrest 
of low  density  cells  in  SFM  was  associated  with  further 
increases  in  a-SM  actin  synthesis  without  changes  in  cell 
density. (c) Growth arrest of low density rapidly dividing cells 
by switching to  SFM  enhanced  a-SM actin  synthesis.  The 
apparent differences in our results and those of Strauch and 
Rubenstein may relate to differences in the cells studied or in 
the culture conditions used. The SFM used in our studies has 
been  shown  to  maintain  SMCs  in  a  viable,  nongrowing, 
positive protein  balance state for extended periods of time 
(22).  In contrast, cells maintained in unsupplemented Dul- 
becco's modified Eagle's medium as used by Strauch  and 
Rubenstein (36),  may have been in negative protein balance 
(22).  An alternative explanation is that one or more of the 
components of SFM had a direct effect on a-SM actin expres- 
sion. This seems unlikely, since there appear to be no differ- 
ences in relative isoactin expression between cells grown in 
SFM +  10% FCS as compared with medium-199 +  10% FCS 
(data not shown).  We want to emphasize that whereas our 
studies did not indicate that cell confluence was an absolute 
349  Owens et al. Lyoactin Expression in Cultured Smooth Muscle Cells Figure 6. Light micrographs of  cultures used for autoradiographic determinations of [3H]thymidine labeling indices in the experiments presented 
in Fig. 5: (a) 2.5 d in FCS; (b) 2.5 d in SFM; (c) 4.5 d in FCS: (d) 4.5 d in SFM; (e) 6,5 d in FCS; (f) 6.5 d in SFM. Marked increases in cell 
density occurred with time in cells grown in SFM +  10% FCS. In contrast, both the frequency of labeled cells and cell density were extremely 
low at all time points examined in cells maintained  in SFM alone. Cells were stained with hematoxylin. Bar, 25 um. 
prerequisite  for a-SM  actin  induction,  they do  support  the 
suggestion of Strauch and  Rubenstein  that cell-cell contact 
has an important permissive effect in that induction was more 
rapid  in density-arrested cultures than in SFM-arrested  sub- 
confluent  cultures.  Furthermore,  the  density-induced  in- 
creases in a-SM actin expression occurred even at fairly high 
rates of cell replication (i.e.,  thymidine indices >20%, Fig. 5). 
The studies presented  here have focused on expression of 
a-SM actin since this is the major actin present  in differen- 
tiated vascular smooth muscle and indeed comprises >25% 
of the  total  protein  in these  cells in  vivo (9,  39).  However, 
there is some evidence that induction of a-SM actin expres- 
sion by growth arrest is accompanied by coordinate induction 
of a  variety of other muscle-specific proteins and functions. 
In the present study results of immunoblot analyses indicate 
that  ~-SM  isoactin  is  also  expressed  in  density-arrested 
postconfluent SMCs. Consistent with these  findings, Franke 
et al.  (10) demonstrated that the mRNA for both a-SM and 
7-SM is present in an established SMC line derived from the 
rat inferior vena cava although they did not specifically ex- 
amine the influence of growth state.  Larsen et al.  (20) have 
presented gel electrophoretic and immunocytochemical data 
showing that myosin is present at all times in cultured SMCs 
from rat mesenteric arteries.  Although Larsen et al. (20) did 
not  observe  any  differences  in  total  myosin  heavy  chain 
content  between  subconfluent  and  postconfluent  cultures, 
they did  observe changes  in  antigenic  expression  based  on 
staining patterns. Furthermore, we have preliminary evidence 
(unpublished  observations) suggesting that  different  myosin 
heavy chain isotypes may be present under these two condi- 
tions. Myosin from postconfluent SMCs was immunoreactive 
in Western blots with an SM-specific polyclonal myosin an- 
tibody (17, obtained from G. Stewart), whereas myosin from 
subconfluent cells was not. Schubert et al. (35) demonstrated 
an increase in the specific activity of creatine phosphokinase 
and myokinase associated with increased cell density and the 
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the  fractional  synthesis of isoactins in  SMC  cultures at  saturation 
density. Cells were plated at 1.0 x  104 cells cm  -2 in SFM +  10% FCS. 
On day  14 after plating, some cells were switched to SFM alone for 
5  d  while  the  remaining  dishes  remained  in  SFM  +  10%  FCS. 
Duplicate  dishes were  analyzed  for  isoactins  at  each  time  point. 
Values represent the mean +  SD.  Replicate dishes from each group 
were pulsed for  1 h  with [3H]thymidine for determination of growth 
rates. Cell number was not different among groups ranging between 
1.20 ×  l0  s and 1.30 ×  105 cells cm  -2. The frequency of[3H]thymidine  - 
labeled cells was 0.64% on day  14, 0.74% on day 19 for cells in SFM 
+  10%  FCS,  and 0.15%  on day  19 for cells in SFM alone. Similar 
results were obtained  in a  separate experiment. •  and A, c~-SM; • 
and (3,  ~-NM; •  and I-1 7-SM  +  ~,-NM; A, ©, and I-q, switched to 
SFM on day  14. 
cessation of cell division in BC3H~ ceils. Subsequently, Olson 
et al. (28) demonstrated that the induction of creatine phos- 
phokinase in these cells occurred at the transcriptional level. 
Chamley-Campbell and Campbell (3) presented morphologi- 
cal evidence suggesting that the loss of contractile  myofila- 
merits in primary smooth muscle cell cultures could be inhib- 
ited by plating cells at a density that inhibited cell growth. 
Taken together, these  cited  studies and  the  present studies 
suggest that expression of a variety of SMC-specific character- 
istics  can  be promoted  in  cultured  SMCs by inhibition  of 
cellular growth. Nevertheless, it is also clear that many char- 
acteristics of differentiated SMCs are altered in cultured cells, 
including  contractile  capability,  morphology,  and  biosyn- 
thetic properties (2, 37, 41) and that further studies are needed 
to determine what additional factors, other than growth con- 
trol, are important in promoting cytodifferentiation in these 
cells. 
The functional significance of changes in isoactin synthesis 
during SMC growth are unclear, but may reflect the physio- 
logical  requirements of cells for specialized actin  molecules 
for specialized cellular functions. For example, the dramatic 
decrease in a-SM synthesis and increase in the relative syn- 
thesis of ~-NM and 3,-actin before onset of DNA synthesis in 
serum-stimulated SMCs  in  the  present study may reflect a 
need for specialized actin  necessary for cell  division.  While 
we did not measure total actin synthesis in our studies, Riddle 
et al. (32) have shown that an increase in total actin synthesis 
precedes onset of DNA synthesis in growth-stimulated fibro- 
blasts. Our results suggest that in SMCs, this increase occurs 
primarily  in  the  nonmuscle  isoactin  forms.  Analogous 
changes occur in skeletal muscle. Whereas prefusion skeletal 
myoblasts contain  principally nonmuscle isoactins, after fu- 
sion a  switching in isoactin synthesis occurs with a-skeletal 
muscle actin becoming the major actin present in differen- 
tiated skeletal muscle (1,  6).  Concurrent with these changes 
in isoactin expression, extensive changes occur in the structure 
and function of actin in skeletal muscle cells. Increased expres- 
sion of SM-specific actins and decreased expression of non- 
muscle actins  has  also been  shown  to  occur during avian 
gizzard development (34)  and during developmental growth 
of the rat thoracic aorta (29),  although it is less clear what 
structural  and  functional  changes  accompany these  altera- 
tions.  Immunocytological studies by Pardo et al.  (30)  dem- 
onstrating differential subcellular localization of muscle and 
nonmuscle  actins  in  skeletal  muscle  cells  provide  further 
support for the idea that isoactins have specialized roles within 
the cell. However, the precise nature of purported functional 
differences in  isoactins are unclear, since  muscle and  non- 
muscle actins appear to have similar physical properties (31) 
and actin binding sites (25). 
Currently, there is much interest in alterations in contractile 
and  cytoskeletal  protein  expression  that  occur  in  vascular 
SMCs in experimental models of atherosclerosis and in hu- 
man atheromatous lesions (11,  13,  15,  19). With  regard to 
actin, recent work (13,  15,  19) has demonstrated that intimal 
SMCs in either experimental or human atheromatous lesions 
contain predominantly ~-NM and 3,-NM  actins rather than 
the a-SM type characteristic of medial SMCs.  Interestingly, 
in a balloon-injury model in rats, Kocher el al. (19) observed 
that in  older lesions (i.e.,  75  d  after injury),  which had re- 
endothelialized, the ratio of SM- to NM-actins had returned 
to levels similar to that of normal medial SMCs. Results of 
the present study suggest that the changes in actin expression 
during lesion development were related to cellular prolifera- 
tion,  and  suggest  that  studies of factors regulating isoactin 
expression  in  cultured  vascular SMCs  may  provide useful 
information on  the  cell  biology and  pathology of vascular 
SMCs in vivo. 
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